Objective:Anemia in the first trimester of pregnancy is the situation as described by the World Health Organization when the level of hemoglobin (Hb) is less than 11 g in 100 cc of blood. The prevalence of this problem is 18% in developed countries, whereas it is between 35-75% in developing countries. In this study, we aimed to determine the prevalence of anemia at the time of pregnancy detection.Materials and Methods:A retrospective cross-sectional study was designed to determine the prevalence of anemia. A total of 5228 first trimester pregnant women were admitted to the study between 2012 and 2014. Hb levels of 11 to 9.5 g/dL, 9.5 to 8 g/dL, and less than 8 g/dL were considered as mild, moderate, and severe anemia, respectively.Results:We detected mild, modarate, and severe anemia at rates of 16.64%, 3.07%, and 0.28%, respectively, in our population. The overall prevalence of anemia at the time of detection of pregnancy was 20.0%.Conclusion:Anemia is a significant risk factor for maternal mortality in developing countries. The prevalence of anemia at the time of pregnancy detection was 20% and this rate is close to those indicated in developed countries.
Impetigo herpetiformis (IH) is a very rare type of dermatosis seen in pregnancy. According to the published work, IH during pregnancy is associated with the risk of stillbirth, and obstetric management in such cases is very important. Early recognition is important to reduce both maternal and fetal morbidity. We present a case of IH resistant to corticosteroid therapy in a 27-year-old pregnant woman where the pregnancy was terminated by the induction of labor.
Objectives: Discrepancies between abnormal cervical cytology or high-risk human papillomavirus (HR-HPV) status (cytology negative/HPV positive) and subsequent histological findings are a common occurrence. After using co-testing, the discrepancies between the HR-HPV status and cervical cytology have become an issue. In this study, we aimed to determine the characteristics of women with a discrepancy between histology and cytology/HR-HPV status, in terms of diagnosis, review and identification. Material and methods:A total of 52 women, patients of the University Hospital between 2013-2015, with cytohistological or HR-HPV status discrepancy were recruited for the study and retrospectively analyzed. The cytological samples were liquid-based Pap smears, classified according to the 2001 Bethesda system. The HR-HPV status was identified using the Hybrid Capture 2 HR-HPV DNA assay. The histological samples were obtained by cervical biopsy as well as large loop excision of the transformation zone (LLETZ). Results:A cytohistological discrepancy was demonstrated in patients with (-)cytology/HR-HPV(+), ASCUS, LSIL, ASC-H, HSIL, AGC-NOS: 17.3%, 23.07%, 26.9%, 9.5%, 17.3% and 5.7%, respectively. When the degree of atypia in cytology increases, the concurrency of cervical cytology with biopsy also increases. A positive HR-HPV co-test result (19/24, 79.1%) was observed in nearly all CIN2 ≥ (+) cases. Our study emphasizes the significance of HR-HPV testing to determine CIN2 ≥ (+) cases, even in the presence of a normal cytological result. Conclusions:In case of cytohistological or HR-HPV discrepancies, a careful review of the HR-HPV status and the degree of cytological atypia should be performed before further intervention.
This study aims to examine the factors affecting skin incision lengths in caesarean section. Materials and Methods: We enrolled 201 pregnant women who delivered by caesarean section. Skin incision lengths in caesarean section were measured with a ruler on the first postoperative day. We categorized the patients into two groups, where group 1 had their caesarean sections performed by senior residents and group 2 by specialists. Demographic patient data, estimated fetal weights, and skin incision lengths were calculated. Results: Patients age was 28.7±4.7 years, gravidity was 2.2±1.0, parity was 1.0±0.7, body mass index (BMI) was 25.2±4.3, and estimated fetal weight was 3.315±425 g. Skin incision lengths were 156.9±14, 159.5±13.1, and 154.5±14.8 mm for all surgeons, only senior residents and only specialists, respectively. Skin incision length was correlated with fetal weight, maternal BMI, gravidity, and parity. In additions, skin incisions made by specialists were smaller skin than those made by residents. Conclusion: Surgical experience is not the only factor affecting the skin incisions in caesarean section; fetal weight, maternal BMI, gravidity, and parity also affect skin incision length. Amaç: Bu çalışma, sezaryen cilt insizyonlarının etkileyen faktörleri araştırmayı amaçladı. Gereç ve Yöntem: Çalşımaya sezaryen ile doğum yapan 201 gebe dahil edildi. Sezaryen sonrası cilt insizyon uzunlukları mezure ile postoperatif birinci günde ölçüldü. Hastalar iki grupta değerlendirildi, birinci grubu uzmanlık öğrencileri tarafından gerçekleştirilen sezaryenler oluştururken, ikinci grubu uzmanlar tarafından gerçekleştirilenler oluşturdu. Hastaların demografik verileri, beklenen fetal ağırlıkları ve insizyon uzunlukları değerlendirildi. Bulgular: Hastaların yaşları 28.7±4.7 yıl, gravida 2.2±1.0, parite 1.0±0.7, vücut kitle indeksleri (BMI) 25.2±4.3 ve beklenen fetal ağırlık 3.315±425 gr idi. Cilt insizyon uzunlukları tüm cerrahlar için (sadece uzmanlık öğrencisi ve uzmanlar) 156.9±14, 159.5±13.1, ve 154.5±14.8 idi. Cilt insizyon uzunlukları, fetal ağırlık, maternal BMI, gravid ve parite ile korrele edildi. Ayrıca uzmanlar tarafından yapılan cilt insizyonları, uzmanlık öğrencilerine göre daha küçük idi. Sonuç: Sezaryen cilt insizyon uzunuluğu sadece cerrahi tecrübe değil, ayrıca fetal ağırlık, maternal BMI, gravid ve paritede etkilemektedir.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.